Literature DB >> 8376578

Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young.

F Sun1, B Knebelmann, M E Pueyo, H Zouali, S Lesage, M Vaxillaire, P Passa, D Cohen, G Velho, C Antignac.   

Abstract

Missense and nonsense mutations in the glucokinase gene have recently been shown to result in maturity-onset diabetes of the young (MODY), a subtype of non-insulin-dependent diabetes mellitus with early age of onset. Glucokinase catalyzes the formation of glucose-6-phosphate and is involved in the regulation of insulin secretion and integration of hepatic intermediary metabolism. Nucleotide sequence analysis of exon 4 and its flanking intronic regions of the glucokinase gene, in four hyperglycemic individuals of a MODY family, revealed a deletion of 15 base pairs, which removed the t of the gt in the donor splice site of intron 4, and the following 14 base pairs. This deletion resulted in two aberrant transcripts, which were analyzed by reverse transcription of RNA from lymphoblastoid cells obtained from a diabetic patient. In one of the abnormal transcripts, exon 5 is missing, while in the other, the activation of a cryptic splice site leads to the removal of the last eight codons of exon 4. This intronic deletion in a donor splice site seems to cause a more severe form of glucose intolerance, compared with point mutations described in glucokinase. This might be due to a more pronounced effect on insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376578      PMCID: PMC288255          DOI: 10.1172/JCI116687

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Point mutations in the dystrophin gene.

Authors:  R G Roberts; M Bobrow; D R Bentley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young.

Authors:  G Velho; P Froguel; K Clement; M E Pueyo; B Rakotoambinina; H Zouali; P Passa; D Cohen; J J Robert
Journal:  Lancet       Date:  1992-08-22       Impact factor: 79.321

3.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.

Authors:  P Froguel; H Zouali; N Vionnet; G Velho; M Vaxillaire; F Sun; S Lesage; M Stoffel; J Takeda; P Passa
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

4.  Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments.

Authors:  B Knebelmann; G Deschenes; F Gros; M C Hors; J P Grünfeld; J Zhou; K Tryggvason; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

5.  Mutations away from splice site recognition sequences might cis-modulate alternative splicing of goat alpha s1-casein transcripts. Structural organization of the relevant gene.

Authors:  C Leroux; N Mazure; P Martin
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

6.  Linkage of type 2 diabetes to the glucokinase gene.

Authors:  A T Hattersley; R C Turner; M A Permutt; P Patel; Y Tanizawa; K C Chiu; S O'Rahilly; P J Watkins; J S Wainscoat
Journal:  Lancet       Date:  1992-05-30       Impact factor: 79.321

7.  Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships.

Authors:  M Gidh-Jain; J Takeda; L Z Xu; A J Lange; N Vionnet; M Stoffel; P Froguel; G Velho; F Sun; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease.

Authors:  H Sakuraba; C M Eng; R J Desnick; D F Bishop
Journal:  Genomics       Date:  1992-04       Impact factor: 5.736

9.  Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus.

Authors:  M Stoffel; P Froguel; J Takeda; H Zouali; N Vionnet; S Nishi; I T Weber; R W Harrison; S J Pilkis; S Lesage
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Nonsense mutation of glucokinase gene in late-onset non-insulin-dependent diabetes mellitus.

Authors:  H Katagiri; T Asano; H Ishihara; K Inukai; M Anai; J Miyazaki; K Tsukuda; M Kikuchi; Y Yazaki; Y Oka
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

View more
  7 in total

1.  Assessment of insulin sensitivity in glucokinase-deficient subjects.

Authors:  K Clément; M E Pueyo; M Vaxillaire; B Rakotoambinina; F Thuillier; P Passa; P Froguel; J J Robert; G Velho
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

2.  Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.

Authors:  G Velho; K F Petersen; G Perseghin; J H Hwang; D L Rothman; M E Pueyo; G W Cline; P Froguel; G I Shulman
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 3.  The genetics of non-insulin-dependent diabetes mellitus: tools and aims.

Authors:  M I McCarthy; P Froguel; G A Hitman
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

4.  Abnormal splicing of hepatocyte nuclear factor-1 beta in the renal cysts and diabetes syndrome.

Authors:  L W Harries; S Ellard; R W A Jones; A T Hattersley; C Bingham
Journal:  Diabetologia       Date:  2004-04-15       Impact factor: 10.122

5.  Intrinsic differences between authentic and cryptic 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

6.  Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.

Authors:  T Frebourg; N Barbier; Y X Yan; J E Garber; M Dreyfus; J Fraumeni; F P Li; S H Friend
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

7.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.

Authors:  S Ellard; C Bellanné-Chantelot; A T Hattersley
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.